‘Why Stop At Insulin?’ Senate Democrats Want More List Price Moves From Pharma

 
• By Sarah Karlin-Smith

Pharma was unable to punt all the drug pricing blame to pharmacy benefits managers at the 10 May Senate HELP hearing on affordable insulin, though the PBM-focused fury was more bipartisan.

Lilly CEO David Ricks and Sanofi CEO Paul Hudson testify at Senate HELP Committtee
Lilly CEO David Ricks and Sanofi CEO Paul Hudson testified at the Senate HELP Committee 10 May • Source: Senate HELP Committee

More from Pricing Debate

More from Market Access